Eldridge George A
SEC CIK 1413006 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | SEE REMARKS | 5,022 | — | $2.68M | 20 | 2022-11-18 | 2024-06-14 |
Most active insiders at JBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Balta Elizabeth | See Remarks | — | — |
| 2 | Frohlich Tom | CEO, Dir | — | — |
| 3 | King Andrew James | See Remarks | — | — |
| 4 | Dahms Bradford D. | CFO | — | — |
| 5 | Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Eldridge George A made no open-market trades at JBIO in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-14 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -15.0K | 5,022 | -75% | -$375.4K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +15.0K | 20.0K | +299% | +$32.1K |
| DM | 2024-04-12 | 2024-04-10 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $26.85 | -7,500 | 2,731 | -73% | -$201.4K |
| D | 2024-04-12 | 2024-04-10 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +7,500 | 9,460 | +383% | +$16.1K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +12.5K | 14.5K | +638% | +$26.7K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $31.23 | -12.5K | 1,960 | -86% | -$390.2K |
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.04 | -4,067 | 1,960 | -67% | -$101.8K |
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +4,067 | 3,976 | New | +$8,703 |
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +25.9K | 5,393 | New | +$55.5K |
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -25.9K | 1,960 | -93% | -$649.2K |
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +14.0K | 5,929 | New | +$29.9K |
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $28.43 | -14.0K | 1,960 | -88% | -$397.2K |
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $21.85 | -23.6K | 1,960 | -92% | -$516.8K |
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +23.6K | 13.6K | New | +$50.6K |
| D | 2022-12-02 | 2022-11-30 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +85 | 2,045 | +4% | +$181.90 |
| D | 2022-12-02 | 2022-11-30 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.06 | -85 | 1,960 | -4% | -$1,620 |
| D | 2022-11-28 | 2022-11-23 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.07 | -1,261 | 1,960 | -39% | -$24.0K |
| D | 2022-11-28 | 2022-11-23 | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +1,261 | 3,221 | +64% | +$2,699 |
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.43 | -1,037 | 1,960 | -35% | -$20.1K |
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Jade Biosciences, Inc. | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +1,037 | 2,821 | +58% | +$2,219 |
Purchase Sale Sale after option exercise All abbreviations